Boai Net Debt from 2010 to 2024

300109 Stock   17.75  2.96  20.01%   
Boai NKY's Net Debt is decreasing over the years with stable fluctuation. Overall, Net Debt is projected to go to about -218.8 M this year. Net Debt is the total debt of Boai NKY Pharmaceuticals minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals
 
Net Debt  
First Reported
2009-12-31
Previous Quarter
167.8 M
Current Value
96.9 M
Quarterly Volatility
353.7 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Boai NKY financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Boai NKY's main balance sheet or income statement drivers, such as Depreciation And Amortization of 44.7 M, Interest Expense of 2 M or Selling General Administrative of 21.8 M, as well as many indicators such as . Boai financial statements analysis is a perfect complement when working with Boai NKY Valuation or Volatility modules.
  
This module can also supplement various Boai NKY Technical models . Check out the analysis of Boai NKY Correlation against competitors.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Boai Stock

Boai NKY financial ratios help investors to determine whether Boai Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Boai with respect to the benefits of owning Boai NKY security.